Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: Results from the British childhood cancer survivor study

Journal of Clinical Oncology

Volumn 27, Issue 34, 2009, Pages 5781-5787

  Taylor, Aliki J ^a   Frobisher, Clare ^a   Ellison, David W ^a   Reulen, Raoul C ^a   Winter, David L ^a   Taylor, Roger E ^a   Stiller, Charles A ^a   Lancashire, Emma R ^a   Tudor, Edward C G ^a   Baggott, Christina ^a   May, Shaun ^a   Hawkins, Mike M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC RISK; GLIOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SPINAL CORD TUMOR; GENETIC PREDISPOSITION; GENETICS; MORTALITY; SECOND CANCER; SURVIVAL RATE;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; INFANT; MALE; MENINGIOMA; NEOPLASMS, SECOND PRIMARY; SPINAL CORD NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 73349126728     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.4386     Document Type: Article

References (45)

1. Stiller C: Childhood Cancer in Britain: Incidence, Survival, Mortality. Oxford, United Kingdom, Oxford University Press, 2007
2. Dickerman JD: The late effects of childhood cancer therapy. Pediatrics 119:554-568, 2007
3. Neglia JP, Robison LL, Stovall M, et al: New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 98:1528-1537, 2006
4. Little MP, de Vathaire F, Shamsaldin A, et al: Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78:269-275, 1998
5. Surawicz TS, McCarthy BJ, Kupelian V, et al: Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neurooncology 1:14-25, 1999
6. Cancer Research UK: Cancer Stats. Brain and Central Nervous System Cancer survival statistics. http://info.cancerresearchuk.org/cancerstats/types/brain/ survival/?a=5441
7. Lote K, Egeland T, Hager B, et al: Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: A retrospective study in 379 patients. J Clin Oncol 15:3129-3140, 1997
8. Zhu YJ, Zhu XD, Wang SH, et al: A multivariate analysis of the prognostic factors of grade III gliomas. Chin Med J (Engl) 121:1072-1075, 2008
9. Bauman G, Lote K, Larson D, et al: Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45:923-929, 1999
10. Claus EB, Black PM: Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: Data from the SEER Program, 1973-2001. Cancer 106:1358-1363, 2006
11. Tseng JH, Tseng MY: Survival analysis of children with primary malignant brain tumours in England and Wales: A population-based study. Pediatr Neurosurg 42:67-73, 2006
12. Shinohara C, Muragaki Y, Maruyama T, et al: Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma. Jpn J Clin Oncol 38:730-733, 2008
13. Laws ER, Parney IF, Huang W, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003
14. Polin RS, Marko NF, Ammerman MD, et al: Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres. J Neurosurg 102:276-283, 2005
15. Jeremic B, Milicic B, Grujicic D, et al: Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 129:477-484, 2003
16. Barnholtz-Sloan JS, Sloan AE, Schwartz AG: SEER Survival Monograph. Chapter 25: Cancer of the Brain and Other Central Nervous System. http://seer.cancer.gov/publications/survival/surv-brain.pdf
17. Tseng MY, Tseng JH: Survival analysis for adult glioma in England and Wales. J Formos Med Assoc 104:341-348, 2005
18. RARECARE. Surveillance of Rare Cancers in Europe. Technical report with basic indications for rare cancers and health related macro indications. http://www.rarecare.eu/rare-indicators/WP5-Technical-Report.pdf
19. Cancer Research UK: Statistics and outlook for brain tumours. http://www.cancerhelp.org.uk/help/default.asp?page=5296#gliomas1
20. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
21. Talbäck M, Stenbeck M, Rosén M: Up-to-date long-term survival of cancer patients: An evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 40:1361-1372, 2004
22. Sankila R, Kallio M, Jääskeläinen J, et al: Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland. Comparison of the observed and expected survival rates in a population-based series. Cancer 70:1568-1576, 1992
23. Marosi C, Hassler M, Roessler K, et al: Meningioma. Crit Rev Oncol Hematol 67:153-171, 2008
24. Carret AS, Tabori U, Crooks B, et al: Outcome of secondary high-grade glioma in children previously treated for a malignant condition: A study of the Canadian Pediatric Brain Tumour Consortium. Radiother Oncol 81:33-38, 2006
25. Hawkins MM, Lancashire ER, Winter DL, et al: British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer 50:1018-1025, 2008
26. World Health Organisation: International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). Geneva, Switzerland, WHO, 2000
27. Louis DN, Ohgaki H, Wiestler OD, et al (eds): WHO Classification of Tumours of the Central Nervous System. Lyon, France, International Agency for Research on Cancer, 2007
28. Esteve J, Benhamou E, Raymond L: Statistical Methods in Cancer Research, Volume IV: Descriptive Epidemiology. Lyon, France, IARC Scientific Publication No. 128, 1994
29. Dickman PW, Sloggett A, Hills M, et al: Regression models for relative survival. Stat Med 23: 51-64, 2004
30. Schwartzbaum JA, Fisher JL, Aldape KD, et al: Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494-503, 2006
31. Rees J, Watt H, Jäger HR, et al: Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol [epub ahead of print on July 14, 2008]
32. Danchaivijitr N, Waldman AD, Tozer DJ, et al: Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247:170-178, 2008
33. Cancer Research UK: Statistics and Outlook for Brain Tumours (Meningioma). http://www.cancerhelp.org.uk/help/default.asp?page=5296#mening1
34. Pobereskin LH: The completeness of brain tumour registration in Devon and Cornwall. Eur J Epidemiol 17:413-416, 2001
35. Larjavaara S, Haapasalo H, Sankila R, et al: Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer 99:182-184, 2008
36. Maier H, Ofner D, Hittmair A, et al: Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623, 1992
37. Iwai Y, Yamanaka K, Ikeda H: Gamma knife radiosurgery for skull base meningioma: Long-term results of low-dose treatment. J Neurosurg 109: 804-810, 2008
38. Krayenbühl N, Pravdenkova S, Al-Mefty O: De novo versus transformed atypical and anaplastic meningiomas: Comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery 61:495-503, 2007
39. Nakane Y, Natsume A, Wakabayashi T, et al: Malignant transformation- related genes in meningiomas: Allelic loss on 1p36 and methylation status of p73 and RASSF1A. J Neurosurg 107:398-404, 2007
40. McCarthy BJ, Davis FG, Freels S, et al: Factors associated with survival in patients with meningioma. J Neurosurg 88:831-839, 1998
41. Colli BO, Carlotti CG Jr, Assirati JA Jr, et al: Parasagittal meningiomas: Follow-up review. Surg Neurol 66:S20-S27
42. Kano H, Takahashi JA, Katsuki T, et al: Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41-47, 2007
43. Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up care of survivors of childhood cancer. Guideline No. 76. January 2004. http://www.sign.ac.uk/guidelines/fulltext/76/index.html
44. Children's Cancer and Leukaemia Group (CCLG). Therapy based long term follow up guidelines (Secondary Malignancy). April 2005. www.cclg.org.uk/ library/19/PracticeStatement?LTFU-full.pdf
45. Children's Oncology Group (COG). Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. 2008. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdf